Cargando…
Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial
BACKGROUND: Preoperative supplementation with immunonutrients, including arginine and n-3 fatty acids, has been shown in a number of systematic reviews to reduce infectious complications in patients who have undergone gastrointestinal surgery. Limited information, however, is available on the benefi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447421/ https://www.ncbi.nlm.nih.gov/pubmed/30967908 http://dx.doi.org/10.4254/wjh.v11.i3.305 |
_version_ | 1783408501410758656 |
---|---|
author | Russell, Kylie Zhang, Han-Guang Gillanders, Lyn K Bartlett, Adam SJR Fisk, Helena L Calder, Philip C Swan, Peter J Plank, Lindsay D |
author_facet | Russell, Kylie Zhang, Han-Guang Gillanders, Lyn K Bartlett, Adam SJR Fisk, Helena L Calder, Philip C Swan, Peter J Plank, Lindsay D |
author_sort | Russell, Kylie |
collection | PubMed |
description | BACKGROUND: Preoperative supplementation with immunonutrients, including arginine and n-3 fatty acids, has been shown in a number of systematic reviews to reduce infectious complications in patients who have undergone gastrointestinal surgery. Limited information, however, is available on the benefits of nutritional supplementation enriched with arginine and n-3 fatty acids in patients undergoing liver resection. AIM: To evaluate the effects of preoperative nutritional supplementation enriched with arginine and n-3 fatty acids on inflammatory and immunologic markers and clinical outcome in patients undergoing liver resection. METHODS: Thirty-four patients undergoing liver resection were randomized to either five days of preoperative Impact(®) [1020 kcal/d, immunonutrition (IMN) group], or standard care [no supplementation, standard care (STD) group]. Nutritional status was measured at study entry by subjective global assessment (SGA). Functional assessments (grip strength, fatigue and performance status) were carried out at study entry, on the day prior to surgery, and on postoperative day (POD) 7 and 30. Inflammatory and immune markers were measured at study entry, on the day prior to surgery, and POD 1, 3, 5, 7, 10 and 30. Postoperative complications were recorded prospectively until POD30. RESULTS: A total of 32 patients (17 IMN and 15 STD) were analysed. All except four patients were SGA class A. The plasma ratio of (eicosapentaenoic acid plus docosahexaenoic acid) to arachidonic acid was higher in IMN patients on the day prior to surgery and POD 1, 3, 5 and 7 (P < 0.05). Plasma interleukin (IL)-6 concentrations were elevated in the IMN group (P = 0.017 for POD7). No treatment effect was detected for functional measures, immune response (white cell count and total lymphocytes) or markers of inflammation (C-reactive protein, tumour necrosis factor-α, IL-8, IL-10). There were 10 patients with infectious complications in the IMN group and 4 in the STD group (P = 0.087). Median hospital stay was 9 (range 4–49) d in the IMN group and 8 (3-34) d in the STD group (P = 0.476). CONCLUSION: In well-nourished patients undergoing elective liver resection, this study failed to show any benefit of preoperative immunonutrition. |
format | Online Article Text |
id | pubmed-6447421 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-64474212019-04-09 Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial Russell, Kylie Zhang, Han-Guang Gillanders, Lyn K Bartlett, Adam SJR Fisk, Helena L Calder, Philip C Swan, Peter J Plank, Lindsay D World J Hepatol Randomized Clinical Trial BACKGROUND: Preoperative supplementation with immunonutrients, including arginine and n-3 fatty acids, has been shown in a number of systematic reviews to reduce infectious complications in patients who have undergone gastrointestinal surgery. Limited information, however, is available on the benefits of nutritional supplementation enriched with arginine and n-3 fatty acids in patients undergoing liver resection. AIM: To evaluate the effects of preoperative nutritional supplementation enriched with arginine and n-3 fatty acids on inflammatory and immunologic markers and clinical outcome in patients undergoing liver resection. METHODS: Thirty-four patients undergoing liver resection were randomized to either five days of preoperative Impact(®) [1020 kcal/d, immunonutrition (IMN) group], or standard care [no supplementation, standard care (STD) group]. Nutritional status was measured at study entry by subjective global assessment (SGA). Functional assessments (grip strength, fatigue and performance status) were carried out at study entry, on the day prior to surgery, and on postoperative day (POD) 7 and 30. Inflammatory and immune markers were measured at study entry, on the day prior to surgery, and POD 1, 3, 5, 7, 10 and 30. Postoperative complications were recorded prospectively until POD30. RESULTS: A total of 32 patients (17 IMN and 15 STD) were analysed. All except four patients were SGA class A. The plasma ratio of (eicosapentaenoic acid plus docosahexaenoic acid) to arachidonic acid was higher in IMN patients on the day prior to surgery and POD 1, 3, 5 and 7 (P < 0.05). Plasma interleukin (IL)-6 concentrations were elevated in the IMN group (P = 0.017 for POD7). No treatment effect was detected for functional measures, immune response (white cell count and total lymphocytes) or markers of inflammation (C-reactive protein, tumour necrosis factor-α, IL-8, IL-10). There were 10 patients with infectious complications in the IMN group and 4 in the STD group (P = 0.087). Median hospital stay was 9 (range 4–49) d in the IMN group and 8 (3-34) d in the STD group (P = 0.476). CONCLUSION: In well-nourished patients undergoing elective liver resection, this study failed to show any benefit of preoperative immunonutrition. Baishideng Publishing Group Inc 2019-03-27 2019-03-27 /pmc/articles/PMC6447421/ /pubmed/30967908 http://dx.doi.org/10.4254/wjh.v11.i3.305 Text en ©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Randomized Clinical Trial Russell, Kylie Zhang, Han-Guang Gillanders, Lyn K Bartlett, Adam SJR Fisk, Helena L Calder, Philip C Swan, Peter J Plank, Lindsay D Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial |
title | Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial |
title_full | Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial |
title_fullStr | Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial |
title_full_unstemmed | Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial |
title_short | Preoperative immunonutrition in patients undergoing liver resection: A prospective randomized trial |
title_sort | preoperative immunonutrition in patients undergoing liver resection: a prospective randomized trial |
topic | Randomized Clinical Trial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447421/ https://www.ncbi.nlm.nih.gov/pubmed/30967908 http://dx.doi.org/10.4254/wjh.v11.i3.305 |
work_keys_str_mv | AT russellkylie preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial AT zhanghanguang preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial AT gillanderslynk preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial AT bartlettadamsjr preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial AT fiskhelenal preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial AT calderphilipc preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial AT swanpeterj preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial AT planklindsayd preoperativeimmunonutritioninpatientsundergoingliverresectionaprospectiverandomizedtrial |